Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-10-28

Clinical Trial Update: Study to Assess the Efficacy and Safety of Endolex Forte VErsus Diosmin and Hesperidin in Reducing VeNous Insufficiency [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating Endolex Forte versus diosmin and hesperidin for chronic venous insufficiency; current status is not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Diosmin and hesperidin (diosmin; hesperidin)
  • Endolex Forte

Snippet

Sponsor: SunWave Pharma | Conditions: Chronic Venous Insufficiency | Phase 3 | Status: UNKNOWN